527 related articles for article (PubMed ID: 8099529)
21. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
Sistonen L; Hölttä E; Lehväslaiho H; Lehtola L; Alitalo K
J Cell Biol; 1989 Nov; 109(5):1911-9. PubMed ID: 2572601
[TBL] [Abstract][Full Text] [Related]
22. Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer.
Koomägi R; Stammler G; Manegold C; Mattern J; Volm M
Cancer Lett; 1996 Dec; 110(1-2):129-36. PubMed ID: 9018091
[TBL] [Abstract][Full Text] [Related]
23. Expression of resistance-related proteins in nephroblastoma after chemotherapy.
Volm M; Mattern J; Stammler G; Royer-Pokora B; Schneider S; Weirich A; Ludwig R
Int J Cancer; 1995 Oct; 63(2):193-7. PubMed ID: 7591203
[TBL] [Abstract][Full Text] [Related]
24. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
[TBL] [Abstract][Full Text] [Related]
25. Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.
Oudard S; Levalois C; Andrieu JM; Bougaran J; Validire P; Thiounn N; Poupon MF; Fourme E; Chevillard S
Anticancer Res; 2002; 22(1A):121-8. PubMed ID: 12017273
[TBL] [Abstract][Full Text] [Related]
26. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K
EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
[TBL] [Abstract][Full Text] [Related]
27. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation.
Hill BT; Whelan RD; Hurst HC; McClean S
Cancer; 1994 Jun; 73(12):2990-9. PubMed ID: 7911070
[TBL] [Abstract][Full Text] [Related]
28. Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cells.
Ishikawa H; Kawano MM; Okada K; Tanaka H; Tanabe O; Sakai A; Asaoku H; Iwato K; Nobuyoshi M; Kuramoto A
Br J Haematol; 1993 Jan; 83(1):68-74. PubMed ID: 8094626
[TBL] [Abstract][Full Text] [Related]
29. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma].
Leng WD; Wang DZ; Feng G; He J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692
[TBL] [Abstract][Full Text] [Related]
30. Multidrug resistance in leukaemia.
Baines P; Cumber P; Padua RA
Baillieres Clin Haematol; 1992 Oct; 5(4):943-60. PubMed ID: 1364045
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of topoisomerase II alpha and Her-2/neu in prostatic carcinoma and benign prostatic hyperplasia.
Hasby EA; Saied EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):158-67. PubMed ID: 20029472
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance.
Yu DS; Ma CP; Chang SY
Urol Res; 2000 Apr; 28(2):86-92. PubMed ID: 10850629
[TBL] [Abstract][Full Text] [Related]
33. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas.
Volm M; Mattern J; Efferth T; Pommerenke EW
Anticancer Res; 1992; 12(4):1063-7. PubMed ID: 1354430
[TBL] [Abstract][Full Text] [Related]
34. The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.
Geng M; Wang L; Chen X; Cao R; Li P
Diagn Pathol; 2013 Dec; 8():198. PubMed ID: 24326092
[TBL] [Abstract][Full Text] [Related]
35. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
Stern DF; Heffernan PA; Weinberg RA
Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
[TBL] [Abstract][Full Text] [Related]
36. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
[TBL] [Abstract][Full Text] [Related]
37. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
[TBL] [Abstract][Full Text] [Related]
38. Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases.
Volm M; van Kaick G; Mattern J
Clin Exp Metastasis; 1994 Jul; 12(4):329-34. PubMed ID: 7913670
[TBL] [Abstract][Full Text] [Related]
39. Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas.
Volm M; Koomagi R; Kaufmann M; Mattern J; Stammler G
Clin Exp Metastasis; 1996 May; 14(3):209-14. PubMed ID: 8674274
[TBL] [Abstract][Full Text] [Related]
40. Expression of multidrug resistance-related genes (mdrl, MRP, GST-pi and DNA topoisomerase II) in urothelial cancers.
Kim WJ; Kakehi Y; Wu WJ; Fukumoto M; Yoshida O
Br J Urol; 1996 Sep; 78(3):361-8. PubMed ID: 8881943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
